K-numberK250751
Device nameDualView Catheter
ApplicantTerumo Corporation
Product codeDQO
Device classClass II
Decision dateJul 17, 2025
DecisionSubstantially Equivalent
Regulation870.1200
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The DualView Catheter is a diagnostic imaging catheter designed for intravascular imaging of coronary arteries in patients undergoing transluminal interventional procedures. It combines optical coherence tomography (OCT) at 1300 nm wavelength and 40 MHz ultrasound imaging to obtain 360° cross-sectional images and longitudinal views of vessel walls by rotating and pulling back an imaging core inside a catheter sheath.

Technological characteristics

The DualView Catheter is 2.6 Fr at the imaging window and 3.0 Fr at the proximal shaft, with 1370 mm effective length and uses a 0.014" guidewire. It operates manually with a hydrophilic coating and has a 36-month shelf life after ethylene oxide sterilization. The primary predicate (Dragonfly Optis) is slightly larger (2.7 Fr/3.2 Fr) with slightly shorter length (1350 mm) and 24-month shelf life, while the secondary predicate (Opticross) uses ultrasound only without OCT.

Test standards cited

ISO 10993-1 (biocompatibility), ISO 11135:2014/Amd 1:2018 (ethylene oxide sterilization), IEC 62304 (software standards), IEC 60601-1, IEC 60601-2-18, IEC 60601-1-2, IEC 60825, and IEC 60601-2-37 (electrical safety and EMC). Performance testing included radio-detectability, tensile strength, particle counts, imaging quality, and stent crossability.

Substantial equivalence argument

The DualView Catheter is substantially equivalent because it shares the same intended use (coronary imaging for interventional candidates) and nearly identical technological characteristics—specifically dual OCT/ultrasound imaging modality, comparable dimensions and guidewire compatibility, and manual operation—with the primary predicate Dragonfly Optis. Performance testing, animal studies confirming safety with combined OCT/ultrasound energy, and biocompatibility validation across the shelf life demonstrate functional equivalence, supporting the determination that it poses no greater risk and provides equivalent performance despite minor dimensional and sterilization method differences.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →